NCT03909672

Brief Summary

Introduction: Low back pain is a very prevalent condition in the population and windsurf therapy has been presented as a non-pharmacological treatment currently used in this population. However, there is a lack of studies that evaluate such effects, besides a standardization of application of the technique in this condition. This protocol describes a placebo-controlled, randomized, double-blind study that aims to assess the effectiveness of windsurf therapy in improving pain and other symptoms of individuals with chronic non-specific back pain. Methods: Ninety individuals with chronic nonspecific and localized chronic low back pain from 18 to 59 years, will be recruited according to the inclusion criteria. Afterwards they will be randomized to one of the 2 groups: intervention group (GI) where it will be submitted applied to the windspiration with 2 suctions; and placebo group (GP) with simulated application. Both applications will occur in parallel to the vertebrae from L1 to L5 bilaterally. The application will be performed once a week for eight weeks. The volunteers will be evaluated before treatment (T0), immediately after the first intervention (T1), 4 weeks after treatment (T4) and 8 weeks after treatment (T8). The primary endpoint will be pain, and the secondary ones will be kinesiophobia, physical function, lumbar range of motion, sleep quality, patient expectation, quality of life, and psychological factors. Discussion: This is the first protocol that proposes to evaluate the effect of windsotherapy on lumbar ROM, sleep quality, kinesiophobia and psychological problems. Few studies have been done on windsurfing individuals with low back pain, requiring further studies with good methodological quality. Because there is no consensus on the use of windsurf therapy in individuals with nonspecific chronic low back pain, our protocol will be the basis for the use of the technique by health professionals and for new studies to be performed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable low-back-pain

Timeline
Completed

Started Jun 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 6, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 10, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

June 10, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2020

Completed
Last Updated

February 21, 2020

Status Verified

February 1, 2020

Enrollment Period

6 months

First QC Date

April 6, 2019

Last Update Submit

February 20, 2020

Conditions

Keywords

low back paincupping therapy

Outcome Measures

Primary Outcomes (1)

  • Change from Numeric Rating Scale (NRS) of Pain

    The patients are asked to circle the number between 0 and 10. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'

    T0 -baseline, T4 (four week) and T8 (eight week)

Secondary Outcomes (7)

  • Change from Oswestry Disability Index (ODI)

    T0 -baseline and T8 (eight week)

  • Range of motion of the lower back (ROM)

    T0 -baseline, T4 (four week) and T8 (eight week)

  • Short-Form 36 questionnaire (SF-36)

    T0 -baseline and T8 (eight week)

  • Timed Up and Go Test (TUG):

    T0 -baseline and T8 (eight week)

  • Global Perceived Effect Scale (GPE)

    T8 (eight week)

  • +2 more secondary outcomes

Study Arms (2)

Cupping therapy with 2 suctions

EXPERIMENTAL

Participants in the intervention group will receive the application of cupping therapy with two acrylic type 1 cups with a distance of 3 cm each cup, parallel to the L1 to L5 vertebrae bilaterally. This group will consist of the application of windsheets with 2 suctions for 10 minutes, once a week, for 10 weeks. The cups shall be secured by means of elastic bands.

Other: Cupping Therapy

Cupping Therapy sham

PLACEBO COMPARATOR

The placebo group will receive the application of cupping therapy with 2 cups of acrylic type size 1 with a distance of 3 cm each cup, parallel to the vertebrae L1 to L5, bilaterally . This group will consist of applying the sham winds for 10 minutes, once a week for 10 weeks. However, the cups will be made with small holes \<2 mm in diameter to release the negative pressure in seconds. The cups will also be fixed by means of elastic bands.

Other: Cupping Therapy

Interventions

application of cupping therapy with two acrylic type 1 cups (4.5 cm internal diameter, Dong Yang ® brand) with a distance of 3 cm each cup, parallel to the L1 to L5 vertebrae bilaterally

Cupping Therapy shamCupping therapy with 2 suctions

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • female and male individuals aged between 18 and 59 years, normal BMI, presenting localized and non-specific lower back pain for more than 3 months;
  • have not used cupping therapy before;
  • report pain between 3 and 8 by NRS;
  • individuals who are not under physiotherapeutic treatment during the intervention;
  • individuals without neurological, vestibular, visual or auditory deficits that make evaluations impossible.

You may not qualify if:

  • Individuals with cutaneous lesions in the region where they will be applied to cupping therapy,
  • Individuals with uncontrolled diabetes and hypertension;
  • Irradiated and sacral lumbar pain;
  • Individuals with contraindication to windsurf therapy, are: cancer, renal failure, hepatic and cardiac insufficiency, pacemaker, pregnancy;
  • Individuals with severe spinal pathology (including fractures, inflammatory diseases and tumors);
  • Travel planning in the next 2 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marcelo Souza

Santa Cruz, Rio Grande do Norte, 59200-000, Brazil

Location

Related Publications (4)

  • Wang YT, Qi Y, Tang FY, Li FM, Li QH, Xu CP, Xie GP, Sun HT. The effect of cupping therapy for low back pain: A meta-analysis based on existing randomized controlled trials. J Back Musculoskelet Rehabil. 2017 Nov 6;30(6):1187-1195. doi: 10.3233/BMR-169736.

    PMID: 28946531BACKGROUND
  • Moura CC, Chaves ECL, Cardoso ACLR, Nogueira DA, Correa HP, Chianca TCM. Cupping therapy and chronic back pain: systematic review and meta-analysis. Rev Lat Am Enfermagem. 2018 Nov 14;26:e3094. doi: 10.1590/1518-8345.2888.3094.

  • Almeida Silva HJ, Barbosa GM, Scattone Silva R, Saragiotto BT, Oliveira JMP, Pinheiro YT, Lins CAA, de Souza MC. Dry cupping therapy is not superior to sham cupping to improve clinical outcomes in people with non-specific chronic low back pain: a randomised trial. J Physiother. 2021 Apr;67(2):132-139. doi: 10.1016/j.jphys.2021.02.013. Epub 2021 Mar 20.

  • Silva HJA, Saragiotto BT, Silva RS, Lins CAA, de Souza MC. Dry cupping in the treatment of individuals with non-specific chronic low back pain: a protocol for a placebo-controlled, randomised, double-blind study. BMJ Open. 2019 Dec 22;9(12):e032416. doi: 10.1136/bmjopen-2019-032416.

MeSH Terms

Conditions

Low Back Pain

Interventions

Cupping Therapy

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Marcelo Cardoso De Souza, PT,PhD

    Universidade Federal do Rio Grande do Norte

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 6, 2019

First Posted

April 10, 2019

Study Start

June 10, 2019

Primary Completion

December 10, 2019

Study Completion

February 20, 2020

Last Updated

February 21, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

there isn't a plan to make individual participant data (IPD) available to other researchers.

Available IPD Datasets

Study Protocol Access

Locations